Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

AAM. 2022; 11(1): 38-47


An Anti-pseudomonal Activity of Suwarna-prash, Blended With Emblica officinalis And Its Components

Kavita Singh, Brij Mohan Singh, Gopal Nath.




Abstract

Pseudomonas is a common cause of nosocomial infection and may lead to neonatal septicaemia. The present in vitro study was planned to understand the rationality of using the Suwarnaprash, Suwarnaprash blended with fresh fruit's extract or powder of Amalaki (Emblica officinalis Gaertn.) in addition to components of various Prash. The Suwarnaprash is an amalgamation of incinerated Swarna bhasma, honey and clarified butter oil (CBO).
The life-threatening pathobiont, i.e. Pseudomonas aeruginosa was cultured on the sterile Mueller–Hinton agar plate surface and kept in an incubator overnight (24 hours). The Aamlaki powder, fresh extract of Aamlaki fruits, distilled water-diluted Swarna bhasma, pure honey, clarified butter oil, Suwarnaprash, Suwarna-Aamlaki prash-I consisting powder of Aamlaki with Suwarnaprash and Suwarna-Aamlaki prash-II includes fresh extract of Aamlaki with Suwarnaprash were inoculated on lawned petri plates in a quantity of 10 µl, 10 µl,10 µl, 0.04 g (~1 drop), 10 µl, 0.2 g, 0.2 g and 20 µl, respectively.
The amalgamation of powder of Emblica officinalis with Suwarnaprash and the Amalaki powder (Emblica officinalis) have shown 20 mm inhibitory zones compared to the 10 mm inhibitory zone of Suwarnaprash.
The result suggests that Suwarna-Amalaki prash-I and Amalaki (Emblica officinalis) powder are more potent to inhibit the growth of Pseudomonas aeruginosa in vitro than any other trial sample. Therefore, Suwarna-Amalaki prash-I may be considered a Suwarnaprash of choice for preventing Pseudomonas aeruginosa induced septicaemia than the Suwarnaprash alone under the Jatakarma Samskara as an additional property.

Key words: Emblica officinalis, Suwarna-prash, Antipseudomonal activity, Disk diffusion method






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.